Regular sunscreen use is a cost-effective approach to skin cancer prevention in subtropical settings
- PMID: 19536149
- DOI: 10.1038/jid.2009.141
Regular sunscreen use is a cost-effective approach to skin cancer prevention in subtropical settings
Abstract
In many developed countries, total costs to health systems for cutaneous basal cell carcinomas (BCCs) and squamous cell carcinomas (SCCs) are among the highest of all cancers, yet the investment value of preventive measures remains unknown. Using primary data from a randomized controlled trial, we estimated the cost-effectiveness of a skin cancer prevention initiative based on regular sunscreen use. Compared with usual practice (discretionary use), the sunscreen intervention cost an additional USD 106,449 (2007) to prevent 11 BCCs, 24 SCCs, and 838 actinic keratoses among 812 residents over 5 years. These health outcomes required an annual average investment of USD 0.74 per person and saved the Australian government a total of USD 88,203 in health-care costs over the same period. Such community-based interventions promoting regular sunscreen use among Caucasians in subtropical settings can prevent skin cancer and related skin tumors in practical ways and with great cost efficiency.
Comment in
-
Analyzing the cost of preventing nonmelanoma skin cancer.J Invest Dermatol. 2009 Dec;129(12):2745-6. doi: 10.1038/jid.2009.237. J Invest Dermatol. 2009. PMID: 19901945
Similar articles
-
Analyzing the cost of preventing nonmelanoma skin cancer.J Invest Dermatol. 2009 Dec;129(12):2745-6. doi: 10.1038/jid.2009.237. J Invest Dermatol. 2009. PMID: 19901945
-
Prolonged prevention of squamous cell carcinoma of the skin by regular sunscreen use.Cancer Epidemiol Biomarkers Prev. 2006 Dec;15(12):2546-8. doi: 10.1158/1055-9965.EPI-06-0352. Epub 2006 Nov 28. Cancer Epidemiol Biomarkers Prev. 2006. PMID: 17132769 Clinical Trial.
-
Evaluation of the Use of Capecitabine for the Treatment and Prevention of Actinic Keratoses, Squamous Cell Carcinoma, and Basal Cell Carcinoma: A Systematic Review.JAMA Dermatol. 2020 Oct 1;156(10):1117-1124. doi: 10.1001/jamadermatol.2020.2327. JAMA Dermatol. 2020. PMID: 32639538
-
Health system costs of skin cancer and cost-effectiveness of skin cancer prevention and screening: a systematic review.Eur J Cancer Prev. 2015 Mar;24(2):141-9. doi: 10.1097/CEJ.0000000000000056. Eur J Cancer Prev. 2015. PMID: 25089375 Review.
-
Regular Application of Sunscreen Can Prevent Skin Cancer.J Cosmet Sci. 2020 Jul/Aug;71(4):191-198. J Cosmet Sci. 2020. PMID: 33022203 Review.
Cited by
-
Examination of a Novel Intervention Strategy to Promote Sunscreen Use: A Feasibility Study.J Clin Aesthet Dermatol. 2024 Jul;17(7):20-22. J Clin Aesthet Dermatol. 2024. PMID: 39006811 Free PMC article.
-
Dermatologic manifestations in patients with the Hermansky-Pudlak syndrome types 1 and 3.Orphanet J Rare Dis. 2022 Jul 30;17(1):305. doi: 10.1186/s13023-022-02464-w. Orphanet J Rare Dis. 2022. PMID: 35907869 Free PMC article.
-
Estimated Healthcare Costs of Melanoma and Keratinocyte Skin Cancers in Australia and Aotearoa New Zealand in 2021.Int J Environ Res Public Health. 2022 Mar 8;19(6):3178. doi: 10.3390/ijerph19063178. Int J Environ Res Public Health. 2022. PMID: 35328865 Free PMC article.
-
Topical treatment of actinic keratoses in organ transplant recipients: a feasibility study for SPOT (Squamous cell carcinoma Prevention in Organ transplant recipients using Topical treatments).Br J Dermatol. 2022 Sep;187(3):324-337. doi: 10.1111/bjd.20974. Epub 2022 Jun 14. Br J Dermatol. 2022. PMID: 34988975 Free PMC article. Clinical Trial.
-
A Systematic Review and Meta-Analysis: Evaluation of the β-Human Papillomavirus in Immunosuppressed Individuals with Cutaneous Squamous Cell Carcinoma.Biomedicine (Taipei). 2020 Dec 1;10(4):1-10. doi: 10.37796/2211-8039.1110. eCollection 2020. Biomedicine (Taipei). 2020. PMID: 33854928 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
